Practice Considerations for Participation in the Enhancing Oncology Model

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/op/authors/author-center.

Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).

Brian Bourbeau

Research Funding: Pfizer (Inst)

Natalie Dickson

Employment: Tennessee Oncology

Leadership: OneOncology

Stock and Other Ownership Interests: OneOncology

Consulting or Advisory Role: Via Oncology, AbbVie, Cigna, Blue Cross and Blue Shield of Tennessee

Research Funding: Bristol Myers Squibb (Inst)

Travel, Accommodations, Expenses: Flatiron Health

Blase Polite

This author is an Associate Editor for JCO Oncology Practice. Journal policy recused the author from having any role in the peer review of this manuscript.

Honoraria: American Journal of Managed Care, Genzyme

Consulting or Advisory Role: Cancer Expert Now, Janssen Oncology, Cellicon Biotechnologies

Speakers' Bureau: Natera

Travel, Accommodations, Expenses: Tapestry Pharmaceuticals

Open Payments Link: https://openpaymentsdata.cms.gov/physician/1196539/summary

No other potential conflicts of interest were reported.